492 filings
Page 10 of 25
8-K
hlxt70wf7 e77t08w
22 Apr 13
Other Events
12:00am
8-K
mwi5q8p6 jdhr2
1 Apr 13
Medivation and Astellas Provide Update on PREVAIL
12:00am
S-8
5bjyouh
12 Mar 13
Registration of securities for employees
12:00am
8-K
fqpcufdp
28 Feb 13
Medivation Reports Fourth Quarter and Year-end 2012 Financial Results
12:00am
8-K
vky67hvzaod
4 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
kqt40v eo0e8
1 Feb 13
Other Events
12:00am
UPLOAD
iun101ihhjm9wleqg
29 Jan 13
Letter from SEC
12:00am
CORRESP
cbxe4q8habe7b9
22 Jan 13
Correspondence with SEC
12:00am
CORRESP
kihuj
2 Jan 13
Correspondence with SEC
12:00am
UPLOAD
q9ljds 4a762izbc1
21 Dec 12
Letter from SEC
12:00am
8-K
7bdf8 jhe
20 Dec 12
Departure of Directors or Certain Officers
12:00am
8-K
j8sroo0g
12 Dec 12
Departure of Directors or Certain Officers
12:00am
8-K
6enjd2 oz8mwx37z
9 Nov 12
Medivation Reports Third Quarter Financial Results
12:00am
8-K
j6m2asijutz
1 Nov 12
Other Events
12:00am
8-K
uayr63
25 Oct 12
Other Events
12:00am
8-K
hoqwct y8s9j
22 Oct 12
Other Events
12:00am
8-K
9e71z5onqz
2 Oct 12
Medivation and Astellas Announce New Data From XTANDI® (enzalutamide) Pivotal Study
12:00am
8-K
epd02cv3 9rp25gt5j
24 Sep 12
Medivation Effects a 2-FOR-1 Forward Split of Its Common Stock
12:00am